USD 93.48
(2.3%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 5.14 Billion USD | 1.48% |
2022 | 5.06 Billion USD | 13.15% |
2021 | 4.47 Billion USD | -0.38% |
2020 | 4.49 Billion USD | 18.19% |
2019 | 3.8 Billion USD | 2697.06% |
2018 | 136 Million USD | -8.72% |
2017 | 149 Million USD | -40.16% |
2016 | 248.99 Million USD | -13.24% |
2015 | 287 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 5.08 Billion USD | 0.06% |
2024 Q1 | 5.08 Billion USD | -1.11% |
2023 Q2 | 5.1 Billion USD | -0.12% |
2023 Q1 | 5.1 Billion USD | 0.79% |
2023 Q3 | 5.1 Billion USD | 0.08% |
2023 FY | 5.14 Billion USD | 1.48% |
2023 Q4 | 5.14 Billion USD | 0.73% |
2022 FY | 5.06 Billion USD | 13.15% |
2022 Q4 | 5.06 Billion USD | 16.96% |
2022 Q2 | 4.37 Billion USD | -1.55% |
2022 Q1 | 4.44 Billion USD | -0.69% |
2022 Q3 | 4.33 Billion USD | -1.05% |
2021 FY | 4.47 Billion USD | -0.38% |
2021 Q4 | 4.47 Billion USD | -0.36% |
2021 Q1 | 4.5 Billion USD | 0.24% |
2021 Q2 | 4.5 Billion USD | -0.07% |
2021 Q3 | 4.49 Billion USD | -0.2% |
2020 Q2 | 4.5 Billion USD | 18.93% |
2020 FY | 4.49 Billion USD | 18.19% |
2020 Q4 | 4.49 Billion USD | 0.65% |
2020 Q3 | 4.46 Billion USD | -0.82% |
2020 Q1 | 3.78 Billion USD | -0.45% |
2019 Q1 | - USD | -100.0% |
2019 FY | 3.8 Billion USD | 2697.06% |
2019 Q4 | 3.8 Billion USD | 2.34% |
2019 Q3 | 3.71 Billion USD | -0.67% |
2019 Q2 | 3.74 Billion USD | 0.0% |
2018 Q3 | 202 Million USD | 0.0% |
2018 FY | 136 Million USD | -8.72% |
2018 Q1 | - USD | -100.0% |
2018 Q4 | 136 Million USD | -32.67% |
2017 Q4 | 195 Million USD | 0.0% |
2017 FY | 149 Million USD | -40.16% |
2016 FY | 248.99 Million USD | -13.24% |
2015 FY | 287 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
AptarGroup, Inc. | 1.18 Billion USD | -334.149% |
Baxter International Inc. | 14.36 Billion USD | 64.193% |
Becton, Dickinson and Company | 15.87 Billion USD | 67.61% |
Bausch + Lomb Corporation | 4.56 Billion USD | -12.741% |
Haemonetics Corporation | 873.88 Million USD | -488.552% |
Envista Holdings Corp | 1.65 Billion USD | -211.034% |
ResMed Inc. | 873.93 Million USD | -488.517% |
Teleflex Incorporated | 1.92 Billion USD | -166.992% |
Warby Parker Inc. | 174.45 Million USD | -2848.152% |
West Pharmaceutical Services, Inc. | 309 Million USD | -1564.485% |